During the past decade, Quantum Clinical Services Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Quantum Clinical Services Group" are "Schizophrenia" (4 trials). Many other conditions were trialed in "Quantum Clinical Services Group" in a lesser frequency.

Most popular intervention types in "Quantum Clinical Services Group" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Lurasidone 20 mg" (2 trials), "Placebo" (2 trials), "Haloperidol 10mg" (1 trials), "Lurasidone" (1 trials) and "Lurasidone 40 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quantum Clinical Services Group" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Quantum Clinical Services Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Quantum Clinical Services Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Quantum Clinical Services Group, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".